Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 10.937\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a C/C(=N\Oc1cccc(F)n1)c1ccc(Cl)cc1Cl
b CCCn1c(=S)[nH]c2cc(C(=O)NCC3CCCO3)ccc2c1=O
c C=CCOc1cccc(CNn2cn[nH]c2=S)c1
d CN(Cc1ccccc1F)C(=O)C(Cc1ccccc1)NC(=O)c1ccccc1
Answer: b. CCCn1c(=S)[nH]c2cc(C(=O)NCC3CCCO3)ccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(=S)[nH]c2cc(C(=O)NCC3CCCO3)ccc2c1=O
CCCn1c(=S)[nH]c2cc(C(=O)NCC3CCCO3)ccc2c1=O
4-oxo-N-(oxolan-2-ylmethyl)-3-propyl-2-sulfanylidene-1H-quinazoline-7-carboxamide